Please assess the completion status of the following clinical trial:

Trial Title: Efficacy Study of Homeopathic Potassium Dichromate to Treat Tracheal Secretions in Critically Ill Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients 18yrs and older~* Situated in the Critical Care areas of Sunnybrook Health Sciences Centre including the Critical Care Unit, Cardiovascular Surgery Intensive Care Unit, Ross Tilley Burn Centre and B5/D4 intensive care units.~* They will have been weaned from mechanical ventilation (eg: extubated, face mask or tracheostomy mask, minimal pressure support or CPAP, FiO2 \<0.3) but are unable to be transferred out of the unit due to excessive and/or persistent secretions for at least 48 hours.~* Persistent secretions will be defined as suctioning of greater than every 2 hours or a score of greater than 20-24 MP per day. (In the Critical Care areas, each time a patient is suctioned, secretions are quantified on a scale of 1-3, with MP being mucopurulent in nature).~Exclusion Criteria:~* Those with evidence of untreated respiratory infections or infections treated for less than 48 hours.~* Those patients on high dose steroids as defined by greater than:Fluticasone 125ug inhaler- four puffs twice daily and/or Prednisone 20mg daily orally~* Patients with multiple drug and/or environmental allergies~* Those patients who fail to give informed written consent.~* Those patients currently enrolled in another clinical trial or who have been approached for participation in a trial during the last 30 days.~* Previous enrollment in this study~* Pregnancy- all women of child bearing age will be administered a pregnancy test before inclusion into the study to verify their status.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).